149 related articles for article (PubMed ID: 18178280)
1. Generation of engineered recombinant hepatocyte growth factor cleaved and activated by Genenase I.
Hayata D; Fukuta K; Matsumoto K; Adachi E; Hanada K; Adachi K; Nakamura T
J Biotechnol; 2008 Feb; 133(4):478-85. PubMed ID: 18178280
[TBL] [Abstract][Full Text] [Related]
2. Production of functional hepatocyte growth factor (HGF) in insect cells infected with an HGF-recombinant baculovirus in a serum-free medium.
Wang MY; Yang YH; Lee HS; Lai SY
Biotechnol Prog; 2000; 16(2):146-51. PubMed ID: 10753438
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.
Mizuno K; Tanoue Y; Okano I; Harano T; Takada K; Nakamura T
Biochem Biophys Res Commun; 1994 Feb; 198(3):1161-9. PubMed ID: 8117273
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.
Kawaguchi M; Orikawa H; Baba T; Fukushima T; Kataoka H
FEBS J; 2009 Jul; 276(13):3481-90. PubMed ID: 19456860
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
6. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.
Kirchhofer D; Lipari MT; Santell L; Billeci KL; Maun HR; Sandoval WN; Moran P; Ridgway J; Eigenbrot C; Lazarus RA
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5306-11. PubMed ID: 17372204
[TBL] [Abstract][Full Text] [Related]
7. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
[TBL] [Abstract][Full Text] [Related]
8. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
[TBL] [Abstract][Full Text] [Related]
9. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases.
Arakaki N; Kawakami S; Nakamura O; Ohnishi T; Miyazaki H; Ishii T; Tsubouchi H; Daikuhara Y
Hepatology; 1995 Dec; 22(6):1728-34. PubMed ID: 7489981
[TBL] [Abstract][Full Text] [Related]
11. Characterization of free alpha- and beta-chains of recombinant macrophage-stimulating protein.
Yoshikawa W; Hara H; Takehara T; Shimonishi M; Sakai H; Shimizu N; Shimizu S; Wang MH; Hagiya M; Skeel A; Leonard EJ
Arch Biochem Biophys; 1999 Mar; 363(2):356-60. PubMed ID: 10068459
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
[TBL] [Abstract][Full Text] [Related]
13. Activation of hepatocyte growth factor in monkey stomach following gastric mucosal injury.
Hori T; Ido A; Uto H; Hasuike S; Moriuchi A; Hayashi K; Nakagawa S; Miyazawa K; Kitamura N; Tsubouchi H
J Gastroenterol; 2004; 39(2):133-9. PubMed ID: 15069619
[TBL] [Abstract][Full Text] [Related]
14. Molecular characteristics of HGF and the gene, and its biochemical aspects.
Mizuno K; Nakamura T
EXS; 1993; 65():1-29. PubMed ID: 8422543
[TBL] [Abstract][Full Text] [Related]
15. Tumor cytotoxic activity of HGF-SF.
Higashio K; Shima N
EXS; 1993; 65():351-68. PubMed ID: 8380742
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease.
Mizuno K; Takehara T; Nakamura T
Biochem Biophys Res Commun; 1992 Dec; 189(3):1631-8. PubMed ID: 1482369
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocyte growth factor (HGF) and its therapeutic applications].
Segura-Flores AA; Gálvez-Gastélum FJ; Alvarez-Rodríguez A; Armendáriz-Borunda J
Rev Gastroenterol Mex; 2004; 69(4):243-50. PubMed ID: 15765978
[TBL] [Abstract][Full Text] [Related]
18. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
19. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
[TBL] [Abstract][Full Text] [Related]
20. Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF.
Kaibori M; Inoue T; Oda M; Naka D; Kawaguchi T; Kitamura N; Miyazawa K; Kwon AH; Kamiyama Y; Okumura T
Biochem Biophys Res Commun; 2002 Jan; 290(1):475-81. PubMed ID: 11779195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
